Patent · US Active

Human transferase family members and uses thereof

US8252915B2 · kind B2 · utility

2Cited by

2References

15Claims

0Family size

Assignee

Millennium Pharmaceuticals, Inc. · US

Inventors

Rachel Meyers · Newton, US
John Hunter · Cambridge, US
Fong-Ying Tsai · Newton, US

Key dates

Filing date	Jul 1, 2010
Grant date	Aug 28, 2012
Priority date	—
Expiry date	Jul 1, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides isolated nucleic acids molecules, designated 33877, 47179, 26886, 46743, 27417, 32252, and 53320 nucleic acid molecules, which encode novel human transferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 33877, 47179, 26886, 46743, 27417, 32252, or 53320 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 33877, 47179, 26886, 46743, 27417, 32252, or 53320 gene has been introduced or disrupted. The invention still further provides isolated 33877, 47179, 26886, 46743, 27417, 32252, or 53320 proteins, fusion proteins, antigenic peptides and anti-33877, 47179, 26886, 46743, 27417, 32252, or 53320 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.